Faron Pharmaceuticals Oy (DI) (FARN) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Feb 2022 07:00 AM
RNS
Faron Announces R&D Day
03 Feb 2022 10:40 AM
RNS
Scientific Reports Publishes INFORAAA Results
31 Jan 2022 01:30 PM
RNS
Holdings in Company
31 Jan 2022 07:00 AM
RNS
Juho Jalkanen Appointed Chief Operating Officer
28 Jan 2022 07:00 AM
RNS
Grant of options
24 Jan 2022 07:00 AM
RNS
Faron at Proactive One2One Investor Forum
17 Jan 2022 07:00 AM
RNS
Faron to Present at Redeye Fight Cancer Seminar
05 Jan 2022 07:00 AM
RNS
Faron to Present at H.C. Wainwright BioConnect
04 Jan 2022 07:00 AM
RNS
Faron Appoints Marie-Louise Fjällskog as CMO
21 Dec 2021 07:00 AM
RNS
Faron's financial calendar for 2022
09 Dec 2021 07:00 AM
RNS
Faron Announces Topline MATINS Biomarker Analysis
01 Dec 2021 07:00 AM
RNS
Change in Faron's Management Team
16 Nov 2021 07:00 AM
RNS
Faron to Present at Jefferies Conference 2021
09 Nov 2021 07:00 AM
RNS
Faron awarded EUR 3.8 Million in Arbitration Case
03 Nov 2021 03:55 PM
RNS
Cellular and Molecular Life Sciences Publication
07 Oct 2021 07:00 AM
RNS
Exercise of options
05 Oct 2021 11:30 AM
RNS
Holding(s) in Company
01 Oct 2021 02:00 PM
RNS
Registration of Placing Shares with Trade Register
01 Oct 2021 07:00 AM
RNS
Results of Placing and Issue Price
30 Sep 2021 04:31 PM
RNS
Proposed Issue and Placing of Shares
17 Sep 2021 07:00 AM
RNS
Presentation of Updated MATINS Data at ESMO
09 Sep 2021 07:00 AM
RNS
Faron Announces Presentation at ESMO Congress
07 Sep 2021 07:00 AM
RNS
Faron to Present at H.C. Wainwright Conference
26 Aug 2021 07:00 AM
RNS
Half-Year Financials, January 1 - June 30 2021
25 Aug 2021 07:00 AM
RNS
First Patient Dosed in Phase II/III COVID-19 Trial
28 Jul 2021 07:00 AM
RNS
Notice of Half-Year Report
12 Jul 2021 07:00 AM
RNS
Faron to Host KOL Webinar on Clever-1 Receptor
22 Jun 2021 07:00 AM
RNS
Updated corporate presentation
14 Jun 2021 11:05 AM
RNS
Second Price Monitoring Extn
14 Jun 2021 11:00 AM
RNS
Price Monitoring Extension
14 Jun 2021 07:00 AM
RNS
Bexmarilimab granted key US patent
03 Jun 2021 07:00 AM
RNS
Bexmarilimab results published in CCR
17 May 2021 07:00 AM
RNS
Bexmarilimab shows promising anti-tumour activity
14 May 2021 07:00 AM
RNS
US rights to patent related to Traumakine
10 May 2021 02:30 PM
RNS
Holding(s) in Company
29 Apr 2021 12:45 PM
RNS
Grant of options
23 Apr 2021 01:45 PM
RNS
Result of AGM
23 Apr 2021 01:45 PM
RNS
Board Change
29 Mar 2021 07:00 AM
RNS
Appointment of a Broker
25 Mar 2021 07:45 AM
RNS
Exercise of Options
25 Mar 2021 07:30 AM
RNS
Notice of Faron Pharmaceuticals Ltd's AGM
25 Mar 2021 07:15 AM
RNS
Faron´s Annual Report 2020 published
25 Mar 2021 07:00 AM
RNS
Financial statement January 1 to December 31 2020
22 Mar 2021 07:00 AM
RNS
Bexmarilimab (Clevegen) development update
11 Mar 2021 07:00 AM
RNS
Faron to Present at Oppenheimer Conference
02 Mar 2021 07:00 AM
RNS
Faron to Present at H.C. Wainwright Conference
25 Feb 2021 07:00 AM
RNS
Notice of Full-Year Results and Annual Report
17 Feb 2021 04:30 PM
RNS
Holding(s) in Company
12 Feb 2021 03:00 PM
RNS
Registration of Placing Shares
12 Feb 2021 07:00 AM
RNS
Results of Placing and Issue Price
UK 100

Latest directors dealings